The current drugs for the treatment of osteoporosis mainly include RANKL inhibitors and bisphosphonates [26], estrogen or selective estrogen receptor modulators (SERMs) [27], calcitonin [28, 29], strontium salts [30], and parathyroid hormone (PTH) [31]. This evidence concerns the gene TNFSF11 and osteoporosis.